News
April 5, 2012 — The American College of Cardiology (ACC) released a list of “Five Things Physicians and Patients Should Question” in cardiology as part of Choosing Wisely, an initiative of the ABIM Foundation. The list identifies five targeted, evidence-based recommendations that can support physicians in working with their patients to make wise choices about their care.
April 05, 2012
Technology
April 5, 2012 – Siemens Healthcare has announced that the Somatom Definition Flash dual-source computed tomography (CT) system with the new Stellar Detector – the first fully integrated detector that virtually eliminates electronic noise – has been cleared by the Food and Drug Administration (FDA) for sale and distribution in the United States. The new Stellar Detector further enhances the already outstanding Somatom Definition Flash CT system by delivering high spatial resolution, generating ultra-thin slices and providing an outstanding level of sharpness in CT at impressively low levels of patient radiation. With the combination of the Somatom Definition Flash CT system and the new Stellar Detector, even the finest image details can now be visualized.
April 05, 2012
News
April 5, 2012 - SK Capital Partners, a U.S. based private investment firm, and IBA (Ion Beam Applications S.A.) announced that they have closed on their previously announced agreement to create IBA Molecular, a jointly-owned company derived from IBA’s worldwide radiopharmaceutical division. IBA Molecular is a worldwide leader in the manufacturing and distribution of radioactive isotopes used for medical imaging and therapy, with over 50 locations in the United States, Europe and Asia and employs over 1,000 people. The transaction is valued at approximately €180 million ($239 million). SK Capital will own 60 percent of the recapitalized entity and IBA will retain a 40 percent stake.
April 05, 2012Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
April 5, 2012 — Arterial Remodeling Technologies (ART) reported yesterday that in vivo data strongly suggest that its next-generation bioresorbable stent promotes positive arterial remodeling in a post-angioplasty porcine model at six months follow-up. In addition, acute safety data indicate there have been more than 300 MACE-free consecutive implantations of its bioresorbable stent in its preclinical phase of development.
April 05, 2012Feature
April 4, 2012 — Medtronic Inc. announced that the Symplicity renal denervation system provides safe, significant and sustained blood pressure reduction up to three years in patients with treatment-resistant hypertension, according to data from two clinical trials presented at the American College of Cardiology (ACC) 61st Annual Scientific Session.
April 05, 2012
News
April 4, 2012 — Edwards Lifesciences Corp. reported that longer-term results (? 2 years) from the high-risk Cohort A of the PARTNER Trial – a randomized comparison of patients treated with either surgical aortic valve replacement or the Edwards SAPIEN transcatheter heart valve – were published in The New England Journal of Medicine. The data were concurrently presented at the American College of Cardiology's (ACC) 61st Annual Scientific Session in Chicago.
April 05, 2012Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Technology
April 4, 2012 — Medrad (Bayer) recently introduced the Mark 7 Arterion angiographic contrast injection system. The system is much smaller, lighter-weight, more ergonomic and easier to maneuver than previous Medrad injectors. It also is easier to operate than previous models, requiring less time to position and set up. It has a clearly visible and intuitive user interface to guide the user through proper set-up, and highlights the information need to perform injections.
April 04, 2012
News
New guidelines for CT-guided biopsies of lung nodules significantly reduce radiation exposure, allowing individuals the benefit of the procedure, which may cut down on overall lung cancer deaths. This research was presented at the Society of Interventional Radiology's (SIR) 37th Annual Scientific Meeting in San Francisco.
April 03, 2012News
Incidences of renal complications, specifically acute renal failure (ARF) and new hemodialysis (HD), continue to increase significantly among Medicare beneficiaries (MB) admitted for percutaneous coronary intervention (PCI). This was according to a study presented last week at the American College of Cardiology’s (ACC) 61st Annual Scientific Session.
April 03, 2012Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Feature
A new comparative effectiveness study found older adults with stable coronary disease who underwent coronary artery bypass graft had better long-term survival than those who underwent percutaneous coronary intervention. However, the some experts disagree it was a fair appled-to-apples comparison.
April 03, 2012
News
April 3, 2012 – Abiomed Inc. today announced the successful first human use of the Impella cVAD device, a new, percutaneous Impella ventricular assist device (VAD) that provides peak flow of approximately 4 liters of blood per minute. The Impella cVAD is designed to provide temporary circulatory support and reduce the workload of the heart muscle via a minimally invasive, catheter-based pump that is inserted percutaneously in the cardiac catheterization lab, without the need for surgical intervention.
April 03, 2012
Feature
Stress tests are an important tool to help diagnose narrowed arteries in people who come to the emergency room (ER) with chest pain but are not confirmed as having a heart attack. Scheduling a follow-up exercise stress test before patients leave the ER more than doubles their likelihood of following through with the test, according to research presented at the American College of Cardiology’s 61st Annual Scientific Session in Chicago.
April 02, 2012Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Feature
It seems a picture is worth more than a thousand words for people who see evidence of coronary artery disease, the most common type of heart disease in men and women. Simply seeing a build-up of calcium in the walls of arteries appears to prompt patients to better adhere to both statin therapy and recommendations for weight loss, according to research presented at the American College of Cardiology’s 61st Annual Scientific Session in Chicago.
April 02, 2012News
Interventional radiology treatments re-establish blood flow in people with chronic deep vein thrombosis (DVT), reducing disabling symptoms and improving the quality of life for those afflicted with post-thrombotic syndrome—an under-recognized but frequent long-term complication of DVT. Researchers presented these findings during March's DVT Awareness Month at the Society of Interventional Radiology's (SIR) 37th Annual Scientific Meeting in San Francisco.
April 02, 2012
News
Boston Scientific announced its support of the HORIZONS II AMI clinical trial, which is designed to evaluate the safety and efficacy of the Promus Element Plus everolimus-eluting platinum chromium (PtCr) coronary stent compared to the Omega platinum chromium bare-metal stent in patients experiencing an acute myocardial infarction (AMI). The trial is co-funded by Boston Scientific and The Medicines Company, and the Cardiovascular Research Foundation (CRF) will act as academic research organization (ARO).
April 02, 2012© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now